Conditional ablation of either SHP-2 or PD-1 in myeloid cells resulted in augmented phosphorylation of HOXA10 and IRF8 in vitro and enhanced differentiation, activation, phagocytosis and inflammatory responses in myeloid cells of tumor-bearing mice, leading to diminished tumor growth. The gene discussed is PTPN11; the disease is neoplasm.